Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEST: Intrathecal Ziconotide in Chronic Severe Pain
NCT00076544Phase 3Completed
- Sponsor
- Elan
- Start
- Feb 2004
- Primary completion
- Mar 2005
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ziconotide in chronic pain, sponsored by Elan. Started Feb 2004; status: completed.
02
Drugs
ziconotide
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00076544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076544.